No Detail Found!

CD40 ligand and P-selectin in heterozygous Beta-thalassemia.

Author(s)
Mehmet Ali Cikrikcioglu Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Rabia Bag Soytas Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Elif Kilic Department of Biochemistry, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Aybala Erek Toprak Department of Biochemistry, Medeniyet University Medical Faculty, Istanbul, Turkey
Mustafa Cakirca Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Mehmet Zorlu Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Muharrem Kiskac Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Sebnem Emegil Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Guven Cetin Division of Hematology, Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Elif Ece Dogan Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Yahya Sekin Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Jamshid Hamdard Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Cumali Karatoprak Department of Internal Medicine, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey
Abstract
To investigate platelet functions and measure soluble CD40 ligand, soluble P-selectin, betathromboglobulin and platelet factor 4 levels in the blood of heterozygous beta thalassemia patients. Methods: The cross-sectional case-control study was conducted at Bezmialem Vakif University, Istanbul, Turkey, between September 2013 and April 2014, and comprised heterozygous beta thalassemia patients who were compared with 41 gender-, age- and body mass index-matched controls for platelet function markers. The two groups were also compared for co-morbidities, smoking, and regular medications. Results: Of the 78(78.78) subjects, 50(64%) were women and 28(36%) men with an overall mean age of 39.4±12.7 years (range: 18-79 years). The mean body mass index was 26.3±4.2. The heterozygous beta thalassemia group included 37(47%)subjects[24(65%) females; 13(35%) males] while the control group had 41(53%) [26(63%) females; 15(37%) males]. Soluble CD40 ligand and soluble P-selectin were lower in the heterozygous beta thalassemia group (p=0.009; p=0.010). Beta-thromboglobulin and platelet factor 4 levels were comparable between the groups (p=0.497; p=0.507.) Conclusion: Some platelet functions may be reduced in heterozygous beta thalassemia patients, which may be related to their lower incidence of cerebral and cardiac ischaemic events.
Publication Details
Page(s) 699-704
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 66, Issue: 6, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

77

Views